Broadcom named strategic vendor for Walmart virtualization solutions
Investing.com - Avid Bioservices reported on Tuesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Avid Bioservices announced earnings per share of $-0.01 on revenue of $34.76M. Analysts polled by Investing.com EPS of $0.01 on revenue of $32.05M.
Avid Bioservices 's are down 49% and is trading at $14.88 , still down 52.02% from its 52 week high of $31.01 set on Tuesday, December 28, 2021.
Avid Bioservices follows other major Healthcare sector earnings this month
Avid Bioservices's report follows an earnings beat by AstraZeneca ADR on Thursday, November 10, 2022, who reported EPS of $1.67 on revenue of $10.98B, EPS of $0.77 on revenue of $10.78B.
Medtronic had beat expectations on Tuesday, November 22, 2022 with second quarter EPS of $1.3 on revenue of $7.6B, for EPS of $1.28 on revenue of $7.7B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar